<SEC-DOCUMENT>0001140361-23-032557.txt : 20230630
<SEC-HEADER>0001140361-23-032557.hdr.sgml : 20230630
<ACCEPTANCE-DATETIME>20230630200944
ACCESSION NUMBER:		0001140361-23-032557
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230630
DATE AS OF CHANGE:		20230630

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Leone John
		CENTRAL INDEX KEY:			0001974212

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38442
		FILM NUMBER:		231063260

	MAIL ADDRESS:	
		STREET 1:		1717 PENNSYLVANIA AVENUE NW
		STREET 2:		SUITE 825
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20006

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IBEX Ltd
		CENTRAL INDEX KEY:			0001720420
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		1717 PENNSYLVANIA AVENUE NW
		STREET 2:		SUITE 825
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20006
		BUSINESS PHONE:		(202)289-9898

	MAIL ADDRESS:	
		STREET 1:		1717 PENNSYLVANIA AVENUE NW
		STREET 2:		SUITE 825
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20006

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IBEX Holdings Ltd
		DATE OF NAME CHANGE:	20171023
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2022-12-31</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001720420</issuerCik>
        <issuerName>IBEX Ltd</issuerName>
        <issuerTradingSymbol>IBEX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001974212</rptOwnerCik>
            <rptOwnerName>Leone John</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O IBEX LIMITED</rptOwnerStreet1>
            <rptOwnerStreet2>1717 PENNSYLVANIA AVE. NW SUITE 825</rptOwnerStreet2>
            <rptOwnerCity>WASHINGTON</rptOwnerCity>
            <rptOwnerState>DC</rptOwnerState>
            <rptOwnerZipCode>20006</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
            <isTenPercentOwner>true</isTenPercentOwner>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Shares</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2019739</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By PineBridge Global Emerging Markets Partners II, L.P.</value>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The reported shares are held directly by PineBridge Global Emerging Markets Partners II, L.P. (&quot;GEM II&quot;), a Cayman limited partnership. PineBridge GEM II G.P., L.P. (&quot;GEM II GP&quot;), a Cayman limited partnership, is the 100% owner of the sole general partner of GEM II. Mr. Leone is a director of IBEX Limited (the &quot;Company&quot;) and a member of GEM II GP's investment committee (the &quot;Investment Committee&quot;). The Investment Committee is composed of three members and manages the investment activities of GEM II GP. As a result, Mr. Leone may be attributed beneficial ownership of the reported shares. Mr. Leone disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.</footnote>
    </footnotes>

    <remarks>The Company determined that as of December 31, 2022, the Company no longer qualified as a foreign private issuer. Beginning July 1, 2023, the Reporting Person is subject to Section 16 of the Securities Exchange Act of 1934.

Exhibit 24 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Lisa Lenstrohm, Attorney-in-Fact</signatureName>
        <signatureDate>2023-06-30</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>brhc20055343_ex24.htm
<DESCRIPTION>EXHIBIT 24
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">


  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div>Exhibit 24</div>
      <div style="text-align: center; font-weight: bold;">POWER OF ATTORNEY</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">Know by all these presents that the undersigned hereby constitutes and appoints each of Lisa Lenstrohm, Amy VanDerSchouw and Jaime Schlomberg, and
        any of their substitutes, signing singly, as the undersigned&#8217;s true and lawful attorney-in-fact to:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z90ca9a5a4dd3491ab7804d6c801ca9d6" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>execute for and on behalf of the undersigned, in the undersigned&#8217;s capacity as an officer and/or director of IBEX Limited (the &#8220;Company&#8221;), Forms 3, 4 and 5 in accordance with Section
                16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z9ac9a187c2ba4facada48912f37912c9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Forms 3, 4 or 5, complete and execute any
                amendment or amendments thereto, and timely file such form with the U.S. Securities and Exchange Commission and any stock exchange or similar authority; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="za0b209b30d8d4870991717833a1fdc68" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of or legally
                required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such
                attorney-in-fact may approve in such attorney-in-fact&#8217;s discretion.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 4.3pt;">The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and
        thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of
        substitution or revocation, hereby ratifying and confirming all that each such attorney-in-fact, or such attorney-in-fact&#8217;s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and
        powers herein granted. The undersigned also ratifies hereby any action previously taken by each such attorney in fact that would have been authorized by this Power of Attorney if it had been in effect at the time such action was taken. The
        undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned&#8217;s responsibilities to comply with Section 16
        of the Securities Exchange Act of 1934, as amended.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 4.3pt;">This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and
        5 with respect to the undersigned&#8217;s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 4.3pt;">IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 30th day of June 2023.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zbe2a43244fde465c81e4cae2bbdb14be" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ John Leone</div>
            </td>
            <td style="width: 23%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 27%; vertical-align: top;"><br>
            </td>
            <td style="width: 23%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 27%; vertical-align: top;">
              <div>
                <div>Name: John Leone</div>
              </div>
            </td>
            <td style="width: 23%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
